REBECCA BOYD: Open Payments
NPI 1043785314 · WHITE PINE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 62 payments from 18 companies in 2025. Trend: 2023 $1,414 · 2024 $1,360 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $213 |
| Novo Nordisk Inc | 10 | $177 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Lilly USA, LLC | 5 | $93 |
| Corcept Therapeutics | 3 | $57 |
| Lundbeck LLC | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $45 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
Products named: AIRSUPRA, JARDIANCE, Ozempic, Kerendia, QULIPTA, UBRELVY, REXULTI, Korlym.
Industry payments across TN — which companies pay providers there.
